Strengthening Maternal and Infant Health Resilience Before Weather and Climate Disasters: Preparedness Resources from CDC's Division of Reproductive Health
This report describes opportunities to address emergency preparedness to incorporate the needs of pregnant and postpartum populations.
New Pregnancy Risk Assessment Monitoring System (PRAMS) 2022 Birth Cohort Data
PRAMS data are available to researchers. Researchers may access data for multiple jurisdictions by downloading the datasets from the PRAMS Automated Research File (ARF) web portal. The process is outlined below.
Changes in Health Indicators Among Caregivers — United States, 2015–2016 to 2021–2022
One in five U.S. adults are caregivers to family members or friends with a chronic health condition or disability. Negative associations between caregiving and caregiver health are known. Strategies for supporting caregivers are available. Integrating these strategies with existing programs to address mental health and chronic diseases among this population might improve caregiver well-being.
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024
The 2024 U.S. Medical Eligibility Criteria for Contraceptive Use (U.S. MEC) comprises recommendations for the use of specific contraceptive methods by persons who have certain characteristics or medical conditions. The goals of these recommendations are to remove unnecessary medical barriers to accessing and using contraception and to support person-centered contraceptive counseling and services in a noncoercive manner.
Prevalence of Anal Cytology Screening among Persons with HIV and Lack of Access to High-resolution Anoscopy at HIV Care Facilities
People with HIV at highest risk of anal cancer include gay, bisexual, and other men who have sex with men and transgender women aged 35 years or older as well as other people with HIV aged 45 years or older. Identifying and treating precancerous lesions can reduce anal cancer incidence in these groups.
Human Papillomavirus Vaccination Coverage Among Adolescent Girls Aged 13–17 Years — U.S.-Affiliated Pacific Islands, 2013–2023
Cervical cancer is the fourth most common cancer among women worldwide, and the World Health Organization Western Pacific Region, where the U.S.-affiliated Pacific Islands (USAPI) are located, accounts for one quarter of all estimated cases. Human papillomavirus (HPV) vaccines prevent most cervical cancers and are recommended for girls at age 11–12 years.
Vaccine Value Profile for Neisseria Gonorrhoeae
Neisseria gonorrhoeae infection is a global public health challenge, causing substantial sexual and reproductive health consequences, such as infertility, pregnancy complications and increased acquisition or transmission of HIV.
Progress Toward Elimination of Mother-to-Child Transmission of Hepatitis B Virus — Region of the Americas, 2012–2022
In 2022, 5 million persons in the World Health Organization Region of the Americas (AMR) had chronic hepatitis B virus (HBV) infection, the leading cause of hepatocellular carcinoma and cirrhosis. Hepatitis B birth dose (HepB-BD) vaccination followed by 2–3 additional doses (HepB3) during infancy can prevent chronic infection.
Lead Poisoning in a Mother and Her Four Children Using a Traditional Eye Cosmetic — New York City, 2012–2023
Surma, a traditional eye cosmetic, has been recognized as a source of lead exposure among adults and children. Banned in the United States, surma is often purchased abroad and hand-carried into the country.
The Impact of Adjusting for Hysterectomy Prevalence on Cervical Cancer Incidence Rates and Trends among Women Aged 30 years or Older - United States, 2001-2019
Hysterectomy protects against cervical cancer when the cervix is removed. However, measures of cervical cancer incidence often fail to exclude women with a hysterectomy from the population-at-risk denominator, underestimating and distorting disease burden.
